US awards $1.6 billion to Novavax for Covid-19 vaccine

| Jul 08, 2020, 02:31:53 PM | TOI.in
  • Share
The US announced that it was providing $1.6 billion in funding for the development and manufacture of a COVID-19 vaccine candidate produced by biotech firm Novavax, the largest amount awarded under Operation Warp Speed. The US also said it was providing $450 million to Regeneron for its experimental COVID-19 treatment and prophylaxis, a combination of two antibodies. Novavax has agreed to deliver 100 million doses of its vaccine, potentially by the end of the year. The final stage Phase 3 trial of its vaccine, called NVX-CoV2373, is set to take place this fall.

Top Viral Videos